Disease First choice Second choice Ankylosing spondylitis Etanercept Adalimumab Rheumatoid arthritis First line Infliximab Etanercept second line Rituximab Psoriatic disease Efalizumab Etanercept Ulcerous colitis and fistulating Crohn ’ s disease Infliximab Crohn ’ s disease